DTE Energy 公司 DTP
$51.37 +$0.00 (0.00%)
休市 · Oct 5, 10:20 pm ET
开盘$0.00
昨收$51.37
当日区间$0.00 – $0.00
成交量0.00
市值$10.59B
市盈率（TTM）–
股息率–
DTP 相关新闻
匹配 DTE Energy Co 或代码 DTP 的头条新闻，按最新排序。
- China's first three-component DTP vaccine approved, marking a significant growth milestone for CanSino Biologics. 正面
- Company Q&A | CanSino: The company has laid out plans and is continuously advancing the overseas rollout of its DTP (diphtheria, tetanus, and pertussis) vaccine series portfolio.
- Yaojie Ankang-B (02617): Ji'entai has issued its first batch of clinical prescriptions in multiple provinces, with simultaneous product distribution completed at DTP pharmacies across various regions nationwide.
- Zhifei Biological: Clinical trial application for the acellular DTP vaccine for adolescents and adults has been accepted.
- Hyatt Hotels | 4: Statement of changes in beneficial ownership of securities- A.N.P TRUST #18 THOMAS DTP
- Hyatt Hotels | 4: Statement of changes in beneficial ownership of securities- DON G.C. Trust #1 DTP
- Hyatt Hotels | 4: Statement of changes in beneficial ownership of securities- R.A. G.C. Trust #1 DTP
- Hyatt Hotels | 3: Initial statement of beneficial ownership of securities- DON G.C. Trust #1 DTP
- Hyatt Hotels | 3: Initial statement of beneficial ownership of securities- A.N.P TRUST #18 THOMAS DTP
- Shenzhen Kangtai Biological Products: The adsorbed acellular DTP (component) combination vaccine has commenced Phase III clinical trials.
- Chongqing Pharmaceutical Holdings (000950.SZ): The company's DTP prescription pharmacy business has shown overall positive development.
暂无评论——快来第一个聊聊 DTP。
登录后参与讨论。